University of Sydney opens OSBF

The University of Sydney’s Bosch Institute opened its new core facility - the Oxidative Stress Bioanalytical Facility (OSBF) in the Medical Foundation Building.

The OSBF, funded in part by an ARC LIEF grant with Agilent being the commercial partner, will provide a facility at the University of Sydney for researchers to develop technology and local skills, create a platform for national and international research collaborations, and enable Australia to maintain a leading position in Redox-related research in biology and medicine.

“We’re extremely pleased to have this unique opportunity to partner with Agilent Technologies to establish this world-class facility that places us at the forefront of Redox-related research on a worldwide level,” said Professor Roland Stocker, founder of the Bosch OSBF. “This facility will also allow us to complement and integrate with existing facilities in this area of research in Australia.”

Currently, there is no dedicated research facility for scientists to determine the impact of oxidative stress on tissue damage in both acute infections and inflammation, and also in the ageing process.

“The Bosch OSBF is unique in the world and it provides our researchers with a powerful platform to advance our understanding of the many diseases we study,” said Professor Jonathan Stone, the Executive Director of the Bosch Institute. “In addition, the lab has been equipped with the new Agilent 1290 HPLC coupled with the Agilent 6460 Triple Quadrupole Mass Spectrometer which will further Redox-related research.”

The Bosch OSBF will be available to laboratories in the Bosch Institute and throughout the university and other partnering institutes and universities.